Provenance du réseau au premier degré de Paolo Fiorina
Entité | Type d'entité | Industrie | |
---|---|---|---|
Enthera Srl
Enthera Srl BiotechnologyHealth Technology Enthera Srl develops therapeutic solutions to treat diabetes. The company was founded in 1985 by in October 2016 by Maria Gabriella Camboni, Paolo Fiorina and Francesca D'Addio and is headquartered in Milan, Italy.
6
| Holding Company | Biotechnology | 6 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Paolo Fiorina via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
BIOGEN INC. | Pharmaceuticals: Major | Director/Board Member | |
BioMotiv LLC
BioMotiv LLC BiotechnologyHealth Technology BioMotiv LLC operates as a research institution in the field of therapeutics. It focuses in disease areas and classes of therapeutics such as small molecules, antibodies, proteins, and nucleotides. The company was founded on September 10, 2012 and is headquartered in Cleveland, OH. | Biotechnology | Director/Board Member | |
Iowa State University | College/University | Undergraduate Degree | |
Massachusetts Institute of Technology | College/University | Doctorate Degree | |
Santa Clara University | College/University | Undergraduate Degree | |
Technische Universität München | College/University | Graduate Degree | |
NEWRON PHARMACEUTICALS S.P.A. | Pharmaceuticals: Major | Director/Board Member | |
New England Venture Capital Association, Inc.
New England Venture Capital Association, Inc. Miscellaneous Commercial ServicesCommercial Services New England Venture Capital Association, Inc. is a non-profit organization which operates as a catalyst, and advocate, and a resource for the innovation economy. The company is headquartered in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
DESTINY PHARMA PLC | Pharmaceuticals: Major | Director/Board Member | |
AbbVie Bioresearch Center, Inc.
AbbVie Bioresearch Center, Inc. BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie Bioresearch Center, Inc. is a company that provides drug discovery, development sciences, and biologics research services. The company is based in Worcester, MA. | Biotechnology | Corporate Officer/Principal | |
Abbott Biotech Ventures, Inc.
Abbott Biotech Ventures, Inc. Investment ManagersFinance Abbott Biotech Ventures, Inc. (Abbott Biotech Ventures) is a venture capital subsidiary of Abbott Laboratories. The firm is headquartered in Abbott Park, Illinois. | Investment Managers | Private Equity Investor | |
The Santa Clara University School of Law | College/University | Graduate Degree | |
Washington University School of Law | College/University | Corporate Officer/Principal | |
Polyneuron Pharmaceuticals AG
Polyneuron Pharmaceuticals AG Pharmaceuticals: MajorHealth Technology Polyneuron Pharmaceuticals AG develops drugs for the treatment of autoimmune disorders. It develops drugs for the treatment of anti-MAG neuropathy disease and multifocal motor neuropathy disease. The firm also develops antibody-catch, a platform technology that enables the development of drugs for highly specific interception of autoimmune disease antibodies and focuses on autoimmune diseases of the peripheral nervous system that involve autoantibodies against carbohydrate epitopes. The company was founded by Andreas J. Steck, Beat Ernst, Pascal Hänggi and Ruben Herrendorffin in 2014 and is headquartered in Basel, Switzerland. | Pharmaceuticals: Major | Corporate Officer/Principal | |
CTx Operations, Inc.
CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Director/Board Member | |
Atlas Venture Ltd.
Atlas Venture Ltd. Financial ConglomeratesFinance Atlas Venture Ltd. invests in biotech startup companies. The private company is based in Cambridge. The American company was founded by Christian R Schubert. | Financial Conglomerates | Founder | |
Jnana Therapeutics, Inc.
Jnana Therapeutics, Inc. BiotechnologyHealth Technology Jnana Therapeutics, Inc. provides drug development services. The firm focuses on immunometabolism changing the metabolic pathways in immune cells to affect function; lysosomal function and mucosal defense. The company was founded by Stuart L. Schreiber, Ramnik Xavier, Joanne Kotz and Joel C. Barrish and is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
University of Illinois At Urbana–Champaign | College/University | Doctorate Degree | |
Nitrase Therapeutics, Inc.
Nitrase Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Nitrase Therapeutics, Inc. develops drugs against newly discovered nitration enzyme. The firm provides disease modifying drugs for multiple additional aging-dependent diseases, such as neurodegenerative disease, heart disease and cancer. The company was founded by Irene Griswold-Prenner and is headquartered in Jackson, WY. | Miscellaneous Commercial Services | Director/Board Member | |
Magnolia Neurosciences Corp.
Magnolia Neurosciences Corp. BiotechnologyHealth Technology Magnolia Neurosciences Corp. operates as a drug discovery and development company. The firm focuses on the creation of a novel class of neuroprotective medicines. The company was founded in 2018 and is headquartered in Seattle, WA. | Biotechnology | Director/Board Member | |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Korro Bio, Inc. engages in the development of a bio therapeutics. It focuses on a proprietary platform designed to selectively edit messenger RNA and recode specific codons to effect changes in protein structure and function across multiple tissues. The company was founded by Jean-Fran?ois Formela, Josh Rosenthal, Nessan Bermingham, and Andrew Fraley in 2018 and is headquartered in Cambridge, MA. | Biotechnology | Consultant / Advisor | |
Lassen Therapeutics 1, Inc.
Lassen Therapeutics 1, Inc. Pharmaceuticals: MajorHealth Technology Lassen Therapeutics 1, Inc. develops pharmaceuticals. The company was founded by David King John and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
Ambagon Therapeutics, Inc.
Ambagon Therapeutics, Inc. BiotechnologyHealth Technology Ambagon Therapeutics, Inc. provides healthcare services. It specializes in biotechnology. The company is headquartered in San Francisco, CA. | Biotechnology | Director/Board Member Director/Board Member | |
VectivBio AG
VectivBio AG BiotechnologyHealth Technology VectivBio AG is a clinical-stage biotechnology company. The firm focuses on developing transformational therapeutics for patients living with serious and rare diseases. Its program apraglutide, is a next-generation GLP-2 analog for the treatment of short bowel syndrome (SBS). The company was founded by Luca Santarelli in 2019 and is headquartered in Basel, Switzerland. | Biotechnology | Corporate Officer/Principal | |
Servier SAS
Servier SAS Miscellaneous Commercial ServicesCommercial Services Servier SAS is based in Suresnes, France and has a global presence of subsidiaries in several regions. The French company chooses to reinvest its profits in the discovery of new drugs and is recognized for its quality and medical excellence. The company works with patients at all stages of the drug life cycle to provide them with the most suitable care paths. Servier specializes in research on cardiovascular disease, cancer, diabetes, immuno-inflammatory, and neuro-psychiatric diseases. Servier SAS is a pharmaceutical company that was founded in 1954. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Nephris Srl
Nephris Srl Miscellaneous Commercial ServicesCommercial Services Nephris Srl provides pre-clinical and research services for kidney diseases. The company is based in Milan, Italy. The Italian company was founded in 2021 by Paolo Fiorina, Francesca D'Addio. The CEO is Maria Gabriella Camboni. | Miscellaneous Commercial Services | Founder | |
P33 Chicago
P33 Chicago Investment ManagersFinance P33 Chicago is an American private company. The firm functions as an alternative investment manager. Brad Henderson has been the CEO since 2018. | Investment Managers | Director/Board Member | |
Shire Pharmaceuticals Ltd.
Shire Pharmaceuticals Ltd. BiotechnologyHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals Ltd. is a patient-focused, British innovation-driven pharmaceutical company. The company is based in London, UK. Takeda has a distinguished 240-year history and aspires to bring better health and a brighter future for people worldwide. Shire Pharmaceuticals was founded in 1986. The CEO is Flemming Ørnskov. | Biotechnology | Corporate Officer/Principal | |
AbbVie Ventures LLC
AbbVie Ventures LLC Investment ManagersFinance AbbVie Ventures LLC (AbbVie Ventures) is a venture capital firm, a subsidiary of AbbVie, Inc. founded in 2009. The firm is headquartered in North Chicago, Illinois. | Investment Managers | Private Equity Investor Private Equity Investor |
Statistiques
Internationale
Etats-Unis | 24 |
Italie | 4 |
Royaume-Uni | 3 |
Suisse | 3 |
Allemagne | 2 |
Sectorielle
Health Technology | 19 |
Consumer Services | 7 |
Finance | 6 |
Commercial Services | 5 |
Opérationnelle
Director/Board Member | 20 |
Corporate Officer/Principal | 5 |
Founder | 4 |
Private Equity Investor | 3 |
Undergraduate Degree | 3 |
Relations les plus connectées
- Bourse
- Insiders
- Paolo Fiorina
- Connexions Sociétés